Infliximab in a child with therapy-resistant systemic vasculitis

Sandra W K de Kort; Marion A J van Rossum; Rebecca ten Cate

doi:10.1007/s10067-005-0071-7

Infliximab in a child with therapy-resistant systemic vasculitis

Clin Rheumatol. 2006 Sep;25(5):769-71. doi: 10.1007/s10067-005-0071-7. Epub 2005 Nov 3.

Authors

Sandra W K de Kort¹, Marion A J van Rossum, Rebecca ten Cate

Affiliation

¹ Amphia Hospital, Breda, The Netherlands.

PMID: 16267606
DOI: 10.1007/s10067-005-0071-7

Abstract

Treatment of systemic vasculitides is usually based on the use of corticosteroids and other immunosuppressive drugs. We describe a 10-year-old girl with systemic vasculitis resistant to immunosuppressive treatment who had a rapid and impressive response to treatment with infliximab.

Publication types

Case Reports

MeSH terms

Antibodies, Monoclonal / therapeutic use*
Antirheumatic Agents / therapeutic use*
Child
Female
Humans
Infliximab
Polyarteritis Nodosa / drug therapy*
Polyarteritis Nodosa / pathology
Remission Induction
Treatment Outcome
Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

Antibodies, Monoclonal
Antirheumatic Agents
Tumor Necrosis Factor-alpha
Infliximab